![](https://futurehealthstocks.com/wp-content/uploads/2025/02/National-Institutes-of-Health-NIH-shutterstock-social1.jpg)
States sue Trump administration over billions in NIH indirect cost cuts
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Plus, news about Caliway Biopharmaceuticals, Orca Bio, Alterity Therapeutics and Ascentage Pharma: Roivant discontinues rare lung disease drug: The termination, disclosed in Roivant’s Sign up
Roche’s $8 billion InterMune acquisition, disclosed a decade ago, is now being handed to a specialty pharmaceutical company. Cayman Islands-based Legacy Pharma is run by
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
A group of 22 attorneys general sued the Trump administration Monday over its announcement on Friday that the percentage of NIH research grant funding that
A dairy worker in Nevada was infected with a new type of bird flu that’s different from the version that has been spreading in U.S.
Plasma p-tau217 successfully identified Alzheimer’s pathology in several neurodegenerative syndromes. This included disorders not typically associated with Alzheimer’s disease, like frontotemporal dementia. Alzheimer’s pathology in